Health Net, Inc. (NYSE:HNT) announced today that the Centers for Medicare & Medicaid Services (CMS) notified the company of its intent to impose intermediate sanctions suspending the marketing and enrollment of new members of all Health Net Medicare Advantage Prescription Drug (MAPD) and stand-alone Prescription Drug Plan (Part D) contracts, effective November 20, 2010. The sanctions relate to compliance with certain Part D requirements that were identified in CMS' press release issued today. The suspension does not affect current Health Net Medicare enrollees.
“Health Net takes our obligations to our Medicare members seriously”
"Health Net takes our obligations to our Medicare members seriously," said Jay Gellert, president and chief executive officer of Health Net, Inc. "Our priority is to help ensure our Medicare members have access to quality health care, customer service and the prescription drugs they need."
Gellert added, "We are working closely with CMS to resolve these matters as quickly as possible. We hope in the next months we can demonstrate to CMS that we have successfully addressed the issues they have raised. We are committed to the Medicare program and look forward to serving new Medicare beneficiaries once again."
An Arm and a Leg: The Medicare episode